Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

Pharmacists and Pharmacy Advocates Have Been Calling for Pharmacist Practitioner Scope of Practice and Reimbursement for Decades, but What Happens When We Catch the Bus?

Patients, Consumers, and Caregivers Are Increasingly Interested in Self-Determination and Convenience.

Community-based pharmacists performed mightily at a cost-efficient scale and safety record that rivaled any in the history of health professions.

All fills are not equal in their complexity and cost.

With the rest of the retail world catching up with pharmacy queuing, will it change customer expectations at the counter?

Pharmacy technicians are evolving to new roles, working with new teammates

Despite the economic and structural support, rural, poor, and underserved communities still have wide disparities in health outcomes.

Our wacky health care system can’t pay pharmacies a few more dollars to survive, but we can spend billions of dollars on shipping costs.

Frustrations with the current means of achieving price discrimination have reached a boiling point, but the future remains uncertain.

The pharmacy is no longer considered to offer full service (or to be financially sustainable) without a robust vaccination practice.

As patient access, public health advocates flex their muscles to reduce barriers to care, products, will that continue to translate in marketplace?

Navigating the Transition to Year-Round Immunization

Never have there been so many opportunities for non–dispensing pharmacist roles. At the same time, there has never been such a need to save the dispensing environment.

Recent editorial calls into question role, use of drug coverage for medications that often cost pennies to procure.

Technicians, other support staff stepped up during the pandemic and took on new responsibilities, which should earn them permanent respect.

Unlike in The Wizard of Oz, there may be more of a scare than actual danger from non-physicians prescribing diagnostics, treatments

After not paying attention, looking other way for years, is the pharmacy industry letting patients down again by employing crude methods of controlled substances monitoring?

For almost half a century, the pharmacy business pulled away from serving patients into retailing, spreadsheet wars; COVID-19 changed the game.

Every change in participation offers the opportunity to self-channel to community pharmacies or mail order.

Loosened restrictions will likely create a more pronounced influenza season this fall.

As pharmacy conglomerates race toward controlling patient journey, community pharmacist role remains murky.

Another market innovation continues the bifurcation of the profession's practice as community pharmacies become generics businesses.

Our health care system flunks every available test of public health and population management readiness and response; it is time to call in the cavalry.

In a sector that relies heavily on opacity, who knows what might be found in the government's inquiry?

Rates of influenza and associated hospitalizations demand late-season vigilance.

Pharmacists possess abundant knowledge about health modalities and medications that they should share with patients.

Fees are now so large that "hiding the cheese" will be harder to accomplish in a year and a half.

Community pharmacies may become generics-only dispensers unless manufacturers rethink the bifurcation of prescription drugs.

With additional responsibilities and a wider scope of services comes the need for more effective and efficient delegation.